The semaglutide group had a 0.33 percentage point reduction in HbA1c ( P = .034), a 0.37 mmol/L decrease in total cholesterol ( P = .04) and a 0.29 mmol/L decline in LDL cholesterol ( P = .05) from baseline to 1 year
At the same time, it is necessary to deeply analyze the differentiated molecular mechanisms of drugs under different pathophysiological conditions, focusing on exploring the optimal dosing regimen suitable for sarcopenia patients and optimizing combination therapy strategies to maximize muscle protection benefits
Mild gastrointestinal side effects (mainly nausea and constipation) occurred in 38% of participants, but did not lead to treatment discontinuation
Because they are part of larger health systems, they often have priority access to supply chains
Compounded GLP-1 ODTs are not FDA-approved drug products
However, sticky inflation and strong consumer spending data have kept rate-cut timelines in flux, adding some volatility